Amended Statement of Ownership (sc 13g/a)
January 12 2015 - 4:02PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
(Rule 13d-102)
Information Statement Pursuant to Rules 13d-1 and 13d-2
Under the Securities Exchange Act of 1934
(Amendment No. 1) *
CytoDyn Inc.
(Name of Issuer)
COMMON STOCK, No Par Value
(Title of Class of Securities)
23283M101
(CUSIP Number)
(Holdings as of December 16, 2014)
Check the appropriate box to designate the rule pursuant to which this
Schedule is filed:
[X] Rule 13d-1(b)
[_] Rule 13d-1(c)
[_] Rule 13d-1(d)
* The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which
would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
CUSIP NO. 23283M101
--------------------------------------------------------------------------------
1. NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Paulson Investment Company LLC
TIN 93-0789804
--------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)[_]
(b)[_]
Not Applicable
--------------------------------------------------------------------------------
3. SEC USE ONLY
--------------------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION
OREGON
--------------------------------------------------------------------------------
Number of Shares Beneficially Owned by Each Reporting Person With:
5. Sole Voting Power: 1,007,301 currently excercisable warrants
to purchase shares of common stock of the Issuer
6. Shared Voting Power: 0
7. Sole Dispositive Power: 1,007,031 currently excercisable warrants
to purchase shares of common stock of the Issuer
8. Shared Dispositive Power: 0
--------------------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,007,031 currently excercisable warrants
to purchase shares of common stock of the Issuer
--------------------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
--------------------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
1.77%
--------------------------------------------------------------------------------
12. TYPE OF REPORTING PERSON
BD
--------------------------------------------------------------------------------
|
CUSIP NO. 23283M101
ITEM 1(A) Name of Issuer:
CytoDyn Inc.
ITEM 1(B) Address of Issuer's Principal Executive Offices:
1111 Main Street, Suite 660
Vancouver, Washington 98660
ITEM 2(A) Name of Person Filing:
Paulson Investment Company LLC
ITEM 2(B) Address of Principal Business Office or, if none, Residence:
1331 NW Lovejoy Street, Suite 720
Portland, Oregon 97209
ITEM 2(C) Citizenship:
Oregon
ITEM 2(D) Title of Class of Securities:
COM
ITEM 2(E) CUSIP Number:
23283M101
ITEM 3. If this statement is filed pursuant to (S)(S)240.13d-1(b) or
240.13d-2(b) or (c), check whether the person filing is a:
(a) [X] Broker or dealer registered under section 15 of the Act in
accordance with Rule 13d-1(b)(1)(ii)(A).
(b) [_] Bank as defined in section 3(a)(6) of the Act (15 U.S.C.
78c).
(c) [_] Insurance company as defined in section 3(a)(19) of the Act
(15 U.S.C. 78c).
(d) [ ] Investment company registered under section 8 of the
Investment Company Act of 1940 (15 U.S.C 80a-8).
(e) [_] An investment adviser in accordance with
(S)240.13d-1(b)(1)(ii)(E);
(f) [_] An employee benefit plan or endowment fund in accordance with
(S)240.13d-1(b)(1)(ii)(F);
(g) [_] A parent holding company or control person in accordance with
(S) 240.13d-1(b)(1)(ii)(G);
(h) [_] A savings associations as defined in Section 3(b) of the
Federal Deposit Insurance Act (12 U.S.C. 1813);
(i) [_] A church plan that is excluded from the definition of an
investment company under section 3(c)(14) of the Investment
Company Act of 1940 (15 U.S.C. 80a-3);
(j) [_] Group, in accordance with (S)240.13d-1(b)(1)(ii)(J).
|
ITEM 4 OWNERSHIP
ITEM 4(A): Amount Beneficially Owned:
The share ownership information reported herein realtes to 1,007,031
currently excercisable warrants to purchase shares of common stock of
the Issuer (the "Warrants") held directly by Paulson Investment Company LLC.
ITEM 4(B): Percent of Class:
The Reporting Person believes that the Issuer had 55,752,503
shares of common stock outstandings as of September 30, 2014, based
on the number of outstandings shares disclosed in the Issuer's
Quarterly Report on From 10-Q for the quarter neded August 31,
2014, filed with the SEC on October 10, 2014. Based on the number
of shares of common stock outstanding as described above and calculated
in accordance with Rule 13d-3(d)(1) with respect to securities which
represent a right to acquire an underlying security, the Reporting
Persons beneficially owned 1.77% of the Issuer's outstanding common
stock as of the date of this filing.
ITEM 4(C): Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: 1,007,031
(ii) shared power to vote or to direct the vote: 0
(iii) sole power to dispose or to direct the disposition of: 1,007,031
(iv) shared power to dispose or to direct the disposition of: 0
ITEM 5 Ownership of Five Percent or Less of a Class:
If this statement is being filed to rerport the fact that as of the date hereof
the reporting person has ceased to be the beneficial owner of more than 5
percent of the class of securities, check the following [X].
CUSIP NO. 23283M101
ITEM 6 Ownership of More than Five Percent on Behalf of Another Person:
Not Applicable.
ITEM 7 Identification and Classification of the Subsidiary which Acquired the
Security Being Reported on by the Parent Holding Company:
Not Applicable.
ITEM 8 Identification and Classification of Members of the Group:
Not Applicable.
ITEM 9 Notice of Dissolution of Group:
Not Applicable.
ITEM 10 CERTIFICATION:
By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were acquired in the ordinary
course of business and were not acquired and are not held for the
purpose of or with the effect of changing or influencing the control
of the issuer of the securities and were not acquired and are not held
in connection with or as a participant in any transaction having such
purpose or effect.
|
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.
December 16, 2014
DATE
/s/ Lorraine Maxfield
-------------------------------
SIGNATURE
|
Lorraine Maxfield/Senior VP Corporate Finance
NAME/TITLE
CytoDyn (QB) (USOTC:CYDY)
Historical Stock Chart
From Mar 2024 to Apr 2024
CytoDyn (QB) (USOTC:CYDY)
Historical Stock Chart
From Apr 2023 to Apr 2024
